These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6956415)

  • 21. [Removal of the vitreous body and laser interventions in complicated forms of diabetic retinopathy].
    Fedorov SN; Glinchuk IaI; Semenov AD; Zakharov VD
    Oftalmol Zh; 1982; 37(1):44-7. PubMed ID: 7200597
    [No Abstract]   [Full Text] [Related]  

  • 22. Proliferative diabetic retinopathy: pathophysiology of extraretinal complications and principles of vitreous surgery.
    Michels RG
    Retina; 1981; 1(1):1-17. PubMed ID: 15633404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The place of vitrectomy in certain complications of diabetic retinopathy].
    Limon S; Haut J
    Journ Annu Diabetol Hotel Dieu; 1978; ():189-93. PubMed ID: 651096
    [No Abstract]   [Full Text] [Related]  

  • 24. Diabetic retinopathy: new observations and simple surgical techniques simplified combined vitrectomy with cataract extraction.
    Mortada A
    Metab Pediatr Ophthalmol; 1980; 4(4):213-6. PubMed ID: 7206912
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
    Funatsu H; Yamashita H; Noma H; Mimura T; Sakata K; Hori S
    Br J Ophthalmol; 2004 Aug; 88(8):1064-8. PubMed ID: 15258026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitrectomy in the treatment os severe diabetic retinopathy, with follow-up.
    Mandelcorn M; Machemer R
    Mod Probl Ophthalmol; 1975; 15():226. PubMed ID: 1160902
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dissection of the internal limiting membrane of the retina].
    García Arumí J
    Arch Soc Esp Oftalmol; 2001 May; 76(5):273-4. PubMed ID: 11373699
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ophthalmological therapy at the end of the 20th century].
    Padilla de Alba FJ; Rojas Dosal JA; Wiechers EG; Villaseñor Schwarz A
    Gac Med Mex; 1993; 129(5):361-6. PubMed ID: 7926423
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
    Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
    Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [To carry out the vitreoretinal surgery energetically and steadily].
    Wang J
    Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):245-6. PubMed ID: 12899131
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vitrectomy in treating severe forms of diabetic retinopathy].
    Fedorov SN; Glinchuk IaI; Zakharov VD; Semenov AD
    Oftalmol Zh; 1980; 35(8):464-7. PubMed ID: 7207938
    [No Abstract]   [Full Text] [Related]  

  • 32. Rationale for the treatment of diabetic retinopathy.
    Morse PH
    Trans Ophthalmol Soc U K (1962); 1976 Apr; 96(1):86-9. PubMed ID: 1070865
    [No Abstract]   [Full Text] [Related]  

  • 33. Do vitreoretinal patients benefit from the use of small-gauge instruments?
    Crafoord S
    Acta Ophthalmol; 2008 Mar; 86(2):120-1. PubMed ID: 18373794
    [No Abstract]   [Full Text] [Related]  

  • 34. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Hagedorn M; Esser P; Wiedemann P; Heimann K
    Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Simultaneous intraocular lens implantation during vitreous surgery for treatment of proliferative diabetic retinopathy].
    Hui Y; Wang L; Huang W; Han Q; Wang Y
    Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):598-602. PubMed ID: 12487908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
    Wilczyński M; Dzivgielewski K
    Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetic retinopathy: the current status of therapy.
    Nemchik R
    RN; 1983 Jun; 46(6):34-7, 40, 63. PubMed ID: 6190212
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrent vitreoretinal membranes in intravitreal silicon oil tamponade. Morphologic and immunohistochemical studies].
    Heidenkummer HP; Messmer EM; Kampik A
    Ophthalmologe; 1996 Apr; 93(2):121-5. PubMed ID: 8652975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of diabetic retinopathy.
    Med Lett Drugs Ther; 1976 Dec; 18(25):107-8. PubMed ID: 995064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.